StockData
Cellyan Biotechnology Co., Ltd logo

Cellyan Biotechnology Co., Ltd (HKPD) stock

HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$1.52−0.09 (-5.30%)

Close on Nov 17, 2026Market cap $24.93MP/E –Yield –

Cellyan Biotechnology enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Cellyan Biotechnology's enterprise value was $27.31M on Nov 11, 2026, against $203.45M a year earlier.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$27.31M+165.9%
2025Dec 31, 2025$10.27M–

More Cellyan Biotechnology figures

See a number that looks wrong?